Literature DB >> 2462586

Identification of alpha 2-macroglobulin as a carrier protein for IL-6.

T Matsuda1, T Hirano, S Nagasawa, T Kishimoto.   

Abstract

In this report we demonstrate that alpha 2-macroglobulin (alpha 2M) is a carrier protein for IL-6. IL-6 was found to bind plasma proteins and an immunoblot analysis revealed that the complex between IL-6 and plasma proteins contains alpha 2M. Furthermore, purified alpha 2M bound IL-6. alpha 2M did not inhibit IL-6 activity or its binding to homologous receptor. IL-6 bound to alpha 2M retained its biologic activity and became resistant to treatment with proteases, although free IL-6 was easily degraded. These findings indicate that alpha 2M plays an important role as a carrier protein for IL-6 in serum and makes IL-6 produced at the local inflammatory site available to lymphocytes, hepatocytes, and hematopoietic stem cells, resulting in the induction of the coordinate systemic host defense reactions, such as immune response, acute phase reaction, and hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462586

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 2.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

3.  Trypanosoma cruzi: plasma levels of alpha-2-macroglobulin during experimental murine infections with reticulotropic and myotropic strains.

Authors:  L Isaac; M Pereira; M Santos; E P Sampaio; N R Lima; M J Lage; T C Araújo-Jorge
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

Review 4.  Alpha-2-macroglobulin as a radioprotective agent: a review.

Authors:  Xueying Chen; Xiangbo Kong; Zhaoqiang Zhang; Wei Chen; Jieyu Chen; Huanyang Li; Wanting Cao; Yaping Ge; Silian Fang
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

5.  Concentration of fetal plasma and amniotic fluid interleukin-1 in pregnancies complicated by preterm prelabour amniorrhexis.

Authors:  S G Carroll; A Abbas; Y Ville; N Meher-Homji; K H Nicolaides
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

6.  Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.

Authors:  V A Danis; G M Franic; D A Rathjen; R M Laurent; P M Brooks
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

Review 7.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

8.  Comparison between the protective effects of mycobacterial 65-kD heat shock protein and ovomucoid in pristane-induced arthritis: relationship with agalactosyl IgG.

Authors:  M Ghoraishian; C J Elson; S J Thompson
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

9.  Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.

Authors:  K Mitsuyama; A Toyonaga; E Sasaki; O Ishida; H Ikeda; O Tsuruta; K Harada; H Tateishi; T Nishiyama; K Tanikawa
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

10.  Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency.

Authors:  Yuhsaku Kanoh; Tadashi Ohara; Shin Egawa; Shiro Baba; Tohru Akahoshi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.